SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-13-002503
Filing Date
2013-05-08
Accepted
2013-05-08 17:15:22
Documents
13
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT immy_10q.htm 10-Q 813761
2 EMPLOYMENT AGREEMENT immy_ex102.htm EX-10.2 274718
3 STOCK AND AWARDS PLAN immy_ex103.htm EX-10.3 99692
4 INCENTIVE STOCK AND AWARDS PLAN immy_ex104.htm EX-10.4 61807
5 CERTIFICATION immy_ex311.htm EX-31.1 18335
6 CERTIFICATION immy_ex312.htm EX-31.2 18421
7 CERTIFICATION immy_ex321.htm EX-32.1 8241
  Complete submission text file 0001354488-13-002503.txt   4112723

Data Files

Seq Description Document Type Size
8 immy-20130331.xml EX-101.INS 434852
9 immy-20130331.xsd EX-101.SCH 36173
10 immy-20130331_cal.xml EX-101.CAL 39288
11 immy-20130331_def.xml EX-101.DEF 79482
12 immy-20130331_lab.xml EX-101.LAB 252521
13 immy-20130331_pre.xml EX-101.PRE 180367
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 13825552
SIC: 2834 Pharmaceutical Preparations